Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: J Enzyme Inhib Med Chem. 2016 Jul 17;31(SUP2):148–161. doi: 10.1080/14756366.2016.1193734

Figure 5.

Figure 5.

In vitro IC50 curves for select CYP26A1 or CYP26B1 inhibitors using tazarotenic acid as a probe substrate. Data points represent the average of incubations conducted in triplicate and IC50 values were calculated using a three-parameter inhibition model with the Hill slope fixed to 1.